We examine the effects on patient access, specifically regarding pathways, high value steps, multi-i...
Read moreOur analysts explore NICE's integration of tech appraisals into treatment guidelines for to enable o...
Read moreThe World Evidence, Pricing, and Access (EPA) Congress stands as Europe’s premier event in mar...
Read moreThis expert article focusses on the new proportionate approach, and the international recognition pr...
Read moreWe're thrilled to announce our participation at ISPOR Europe 2023 in Copenhagen this November. We'll...
Read moreWebinar: Our experts discuss NICE's proportionate approach to technology appraisals and the implicat...
Read moreOur study aims to understand how the severity modifier has been implemented so far and its impact on...
Read moreLearn about the ground breaking consultation by NHS England and NICE on expanding the Antimicrobial ...
Read moreWe explore the issues faced by manufacturers and payers for oncology combination pricing and the pot...
Read moreUK, Canada and United States join forces to streamline process and increase transparency for confide...
Read more